Pancreatic Neuroendocrine Tumors, WHO Grade I-II
1 clinical trials · Condition
◉ Watch Pancreatic Neuroendocrine Tumors, WHO Grade I-II
| Record | Firm | Date |
|---|---|---|
| Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms (NCT05243082) | Oslo University Hospital | 2022-01-14 |
Track Pancreatic Neuroendocrine Tumors, WHO Grade I-II automatically
Every clearance here is in the API, with alerts when new ones post.